Projections of future costs of asthma and COPD in the Netherlands

M. Hoogendoorn, T. L. Feenstra, M. P. Rutten-van Mölken (Rotterdam, Bilthoven, Netherlands)

Source: Annual Congress 2005 - Asthma and COPD: management and burden
Session: Asthma and COPD: management and burden
Session type: Thematic Poster Session
Number: 2465
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Hoogendoorn, T. L. Feenstra, M. P. Rutten-van Mölken (Rotterdam, Bilthoven, Netherlands). Projections of future costs of asthma and COPD in the Netherlands. Eur Respir J 2005; 26: Suppl. 49, 2465

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Costs of COPD and asthma in Sweden
Source: Eur Respir J 2004; 24: Suppl. 48, 701s
Year: 2004

Lifetime costs of COPD in the Netherlands
Source: Eur Respir J 2002; 20: Suppl. 38, 124s
Year: 2002

Costs of COPD exacerbations in a general population.
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018

Health care utilization and costs of asthma and COPD in the Netherlands
Source: Eur Respir J 2005; 26: Suppl. 49, 383s
Year: 2005

The costs of exacerbations in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 273s
Year: 2001

Is there a need for pharmacoepidemiology in asthma and COPD?
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004

Cost and effectiveness of 2 years integrated care intervention in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Costs of exacerbations in COPD
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012

Annual direct-cost of asthma and COPD in Turkey
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012

Current and future costs of COPD in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013

Societal costs of severe asthma in Sweden
Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Year: 2018

Cost of asthma in patients treated with national asthma guideline in Turkey
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003

Manner of treatment and costs of COPD exacerbations in secondary medical care in Poland
Source: Eur Respir J 2007; 30: Suppl. 51, 194s
Year: 2007

Hospital readmissions and social deprivation in asthma and COPD
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Exacerbations and healthcare resource utilization among COPD patients in Sweden
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014


The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


The impact of implementing a COPD care bundle on the delivery of care to patients admitted with an acute exacerbation of COPD
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013